Diabetes and the risk of end-stage renal disease (ESRD) in the United States

被引：0
|
作者：
Tarver-Carr, ME
Powe, NR
Eberhardt, MS
Brancati, FL
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
783
引用
收藏
页码：A190 / A190
页数：1
相关论文
共 50 条
  • [31] Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD)
    Frank, T
    Bitsch, R
    Maiwald, J
    Stein, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1999, 37 (09) : 449 - 455
  • [32] Burden of end-stage renal disease (ESRD) in Latin America
    Rosa-Diez, Guillermo
    Gonzalez-Bedat, Maria
    Ferreiro, Alejandro
    Garcia-Garcia, Guillermo
    Fernandez-Cean, Juan
    Douthat, Walter
    CLINICAL NEPHROLOGY, 2016, 86 : S29 - S33
  • [33] Survival of children with HIV-associated nephropathy (HIVAN) and end-stage renal disease (ESRD) in the United States.
    Ahuja, TS
    Kuo, YF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 756A - 756A
  • [34] Peripheral vascular disease (PVD): Is it a risk factor for mortality in end-stage renal disease (ESRD)?
    Chua, BSY
    Szczech, LA
    Frankenfield, DL
    Allen, AS
    Griffith, TF
    Owen, WF
    Reddan, DN
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 262A - 262A
  • [35] TT virus infection in end-stage renal disease (ESRD)
    Fabrizi, F
    Martin, P
    Lunghi, G
    Locatelli, F
    JOURNAL OF NEPHROLOGY, 2001, 14 (02) : 80 - 87
  • [36] Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD)
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (Suppl 1) : 131 - 135
  • [37] Neuropeptide Y (NPY) as a cardiovascular risk factor in end-stage renal disease (ESRD).
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    Benedetto, FA
    Parlongo, S
    Cutrupi, S
    Iellamo, D
    Bonanno, G
    Rapisarda, F
    Fatuzzo, P
    Seminara, G
    Cataliotti, A
    Malatino, LS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 676A - 676A
  • [38] Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD)
    Carmine Zoccali
    Francesca Mallamaci
    Giovanni Tripepi
    European Journal of Clinical Pharmacology, 2006, 62 : 131 - 135
  • [39] END-STAGE RENAL DISEASE A new comorbidity index for estimating mortality risk in ESRD
    Lindholm, Bengt
    Davies, Simon
    NATURE REVIEWS NEPHROLOGY, 2010, 6 (07) : 391 - 393
  • [40] EPIDEMIC END-STAGE RENAL-DISEASE IN THE UNITED-STATES
    MCCLELLAN, WM
    ARTIFICIAL ORGANS, 1994, 18 (06) : 413 - 415
12345